Samira Ismail
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Samira Ismail has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Samia Ali Temtamy
National Research Centre, Cairo, Egypt
8 shared publications - Mona S. Aglan
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt
6 shared publications - Maha Saad Zaki
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt
5 shared publications - Inas Mazen
Clinical Genetics Department, National Research Centre, Cairo, Egypt
3 shared publications - Khalda Sayed Amr
Division of Medical Molecular Genetics, National Research Center, Cairo, Egypt
3 shared publications - Ashleigh E. Schaffer
Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, USA
2 shared publications
Latest Publications
- 29 April 2019
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 180 (5) , 305-309
Study of C677T variant of methylene tetrahydrofolate reductase gene in autistic spectrum disorder Egyptian children
Background: Autism spectrum disorders (ASD) is a heterogeneous neurodevelopmental disease, various articles reported that dysfunctional folate‐methionine pathway enzymes might assume a paramount part in the pathophysiology of autism. Methylene tetrahydrofolate reductase (MTHFR) is a basic catalyst for this pathway, also MTHFR gene C677T variant accounted as a risk factor of autism.Objective: The present study aimed to investigate the association of MTHFR gene rs1801133(C677T) variant among Egyptian autistic children.Methods: The study included 78 autistic children, and 80 matched healthy control children. Full clinical and radiological examinations were conducted. MTHFR genetic variant, rs1801133(C677T) was studied by using polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) methods followed by direct sequencing technique.Results: MTHFR (C677T) allele frequency was found to be higher significantly in ASD cases compared with nonautistic children. Also, we had a higher distribution of combined CT + TT genotypes among autistic patients with consanguinity and family history of psychological disease. In Gastrointestinal tract (GIT) and sleep disorders showed a higher distribution of hetero CT genotype as well as combined CT + TT genotypes.Conclusion: This study demonstrated a role of MTHFR gene (C667T) variant with the increased risk for ASD.
- 29 April 2019
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 180 (5) , 305-309
Study of C677T variant of methylene tetrahydrofolate reductase gene in autistic spectrum disorder Egyptian children
Background: Autism spectrum disorders (ASD) is a heterogeneous neurodevelopmental disease, various articles reported that dysfunctional folate‐methionine pathway enzymes might assume a paramount part in the pathophysiology of autism. Methylene tetrahydrofolate reductase (MTHFR) is a basic catalyst for this pathway, also MTHFR gene C677T variant accounted as a risk factor of autism.Objective: The present study aimed to investigate the association of MTHFR gene rs1801133(C677T) variant among Egyptian autistic children.Methods: The study included 78 autistic children, and 80 matched healthy control children. Full clinical and radiological examinations were conducted. MTHFR genetic variant, rs1801133(C677T) was studied by using polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP) methods followed by direct sequencing technique.Results: MTHFR (C677T) allele frequency was found to be higher significantly in ASD cases compared with nonautistic children. Also, we had a higher distribution of combined CT + TT genotypes among autistic patients with consanguinity and family history of psychological disease. In Gastrointestinal tract (GIT) and sleep disorders showed a higher distribution of hetero CT genotype as well as combined CT + TT genotypes.Conclusion: This study demonstrated a role of MTHFR gene (C667T) variant with the increased risk for ASD.
- 1 July 2017
- Published by Egyptian Knowledge Bank in Middle East Journal of Medical Genetics
- Vol. 6 (2) , 82-87
Nager acrofacial dysostosis with a novel mutation in SF3B4 and developmental retardation in an Egyptian child
Nager syndrome is a rare autosomal dominant genetic disorder with acrofacial dysostosis. The SF3B4 gene, which consists of six exons located at 1q21.2, is the only known gene that causes the syndrome. This is a case report of an Egyptian female patient with clinical manifestations of Nager syndrome. Detailed clinical and orodental examination was performed in addition to needed imaging studies. Sanger sequencing was performed to identify variants in all six exons of the SF3B4 gene. A novel heterozygous p.L96M variant in exon 3 of SF3B4 gene was identified in the affected case and was absent in her parents. In-silico analysis results showed that this nucleotide is highly conserved among species and is disease causing. We report on an Egyptian child with Nager acrofacial dysostosis syndrome with developmental retardation. Diagnosis was based mainly on clinical and radiological manifestations and confirmed by molecular studies that identified a novel mutation in SF3B4.
- 1 July 2017
- Published by Egyptian Knowledge Bank in Middle East Journal of Medical Genetics
- Vol. 6 (2) , 82-87
Nager acrofacial dysostosis with a novel mutation in SF3B4 and developmental retardation in an Egyptian child
Nager syndrome is a rare autosomal dominant genetic disorder with acrofacial dysostosis. The SF3B4 gene, which consists of six exons located at 1q21.2, is the only known gene that causes the syndrome. This is a case report of an Egyptian female patient with clinical manifestations of Nager syndrome. Detailed clinical and orodental examination was performed in addition to needed imaging studies. Sanger sequencing was performed to identify variants in all six exons of the SF3B4 gene. A novel heterozygous p.L96M variant in exon 3 of SF3B4 gene was identified in the affected case and was absent in her parents. In-silico analysis results showed that this nucleotide is highly conserved among species and is disease causing. We report on an Egyptian child with Nager acrofacial dysostosis syndrome with developmental retardation. Diagnosis was based mainly on clinical and radiological manifestations and confirmed by molecular studies that identified a novel mutation in SF3B4.
- 1 January 2017
- Published by Egyptian Knowledge Bank in Middle East Journal of Medical Genetics
- Vol. 6 (1) , 29-34
Clinical and cytogenetic description of three patients with constitutional mosaic trisomy 8
Constitutional mosaic trisomy 8 causes a well-described syndrome with an extremely variable phenotype. Patients with this syndrome have characteristic facial features. In addition, they may have anomalies affecting limbs, the heart, the central nervous system, and kidneys. They may have developmental delay that varies from mild to severe. Moreover, they have an increased tendency to develop hematologic malignancies and solid tumors. In this study we describe three patients with a phenotype consistent with mosaic trisomy 8 of variable severity. Patients were subjected to detailed history taking and thorough clinical examination. Cytogenetic studies including fluorescence in situ hybridization of peripheral blood lymphocytes and buccal mucosal swab were conducted. Peripheral blood kayotyping was performed for all patients. It revealed trisomy 8 in 80–100% of peripheral blood lymphocytes. However, using fluorescence in situ hybridization on buccal swab cells obtained from one patient detected trisomy 8 cell line in only 10% of cells. The difference in the percentages of the trisomic cell line between different tissues may influence the apparent variability in the clinical severity.
- 1 January 2017
- Published by Egyptian Knowledge Bank in Middle East Journal of Medical Genetics
- Vol. 6 (1) , 29-34
Clinical and cytogenetic description of three patients with constitutional mosaic trisomy 8
Constitutional mosaic trisomy 8 causes a well-described syndrome with an extremely variable phenotype. Patients with this syndrome have characteristic facial features. In addition, they may have anomalies affecting limbs, the heart, the central nervous system, and kidneys. They may have developmental delay that varies from mild to severe. Moreover, they have an increased tendency to develop hematologic malignancies and solid tumors. In this study we describe three patients with a phenotype consistent with mosaic trisomy 8 of variable severity. Patients were subjected to detailed history taking and thorough clinical examination. Cytogenetic studies including fluorescence in situ hybridization of peripheral blood lymphocytes and buccal mucosal swab were conducted. Peripheral blood kayotyping was performed for all patients. It revealed trisomy 8 in 80–100% of peripheral blood lymphocytes. However, using fluorescence in situ hybridization on buccal swab cells obtained from one patient detected trisomy 8 cell line in only 10% of cells. The difference in the percentages of the trisomic cell line between different tissues may influence the apparent variability in the clinical severity.
- 1 September 2016
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 20 (5) , 714-722
Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients
- 1 September 2016
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 20 (5) , 714-722
Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients
- Top Cited PapersOpen Access
- 28 September 2015
- Published by Springer Nature in Genome Biology
- Vol. 16 (1) , 1-11
Mutation in WDR4 impairs tRNA m7G46 methylation and causes a distinct form of microcephalic primordial dwarfism
Primordial dwarfism is a state of extreme prenatal and postnatal growth deficiency, and is characterized by marked clinical and genetic heterogeneity. Two presumably unrelated consanguineous families presented with an apparently novel form of primordial dwarfism in which severe growth deficiency is accompanied by distinct facial dysmorphism, brain malformation (microcephaly, agenesis of corpus callosum, and simplified gyration), and severe encephalopathy with seizures. Combined autozygome/exome analysis revealed a novel missense mutation in WDR4 as the likely causal variant. WDR4 is the human ortholog of the yeast Trm82, an essential component of the Trm8/Trm82 holoenzyme that effects a highly conserved and specific (m7G46) methylation of tRNA. The human mutation and the corresponding yeast mutation result in a significant reduction of m7G46 methylation of specific tRNA species, which provides a potential mechanism for primordial dwarfism associated with this lesion, since reduced m7G46 modification causes a growth deficiency phenotype in yeast. Our study expands the number of biological pathways underlying primordial dwarfism and adds to a growing list of human diseases linked to abnormal tRNA modification.
- 28 September 2015
- Published by Springer Nature in Genome Biology
- Vol. 16 (1) , 1-11
Top Cited PapersOpen AccessMutation in WDR4 impairs tRNA m7G46 methylation and causes a distinct form of microcephalic primordial dwarfism
Primordial dwarfism is a state of extreme prenatal and postnatal growth deficiency, and is characterized by marked clinical and genetic heterogeneity. Two presumably unrelated consanguineous families presented with an apparently novel form of primordial dwarfism in which severe growth deficiency is accompanied by distinct facial dysmorphism, brain malformation (microcephaly, agenesis of corpus callosum, and simplified gyration), and severe encephalopathy with seizures. Combined autozygome/exome analysis revealed a novel missense mutation in WDR4 as the likely causal variant. WDR4 is the human ortholog of the yeast Trm82, an essential component of the Trm8/Trm82 holoenzyme that effects a highly conserved and specific (m7G46) methylation of tRNA. The human mutation and the corresponding yeast mutation result in a significant reduction of m7G46 methylation of specific tRNA species, which provides a potential mechanism for primordial dwarfism associated with this lesion, since reduced m7G46 modification causes a growth deficiency phenotype in yeast. Our study expands the number of biological pathways underlying primordial dwarfism and adds to a growing list of human diseases linked to abnormal tRNA modification.
- 18 August 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (12) , 3054-3061
Clinical and molecular characterization of seven Egyptian families with autosomal recessive robinow syndrome: Identification of four novel ROR2 gene mutations
Robinow syndrome (RS) is a rare genetic disorder characterized by limb shortening, genital hypoplasia, and craniofacial/orodental abnormalities. The syndrome follows both autosomal dominant and recessive patterns of inheritance with similar phenotypic presentation and overlapping features. Autosomal recessive Robinow syndrome (ARRS) is caused by mutations in the ROR2 gene. Here, we present the clinical, radiological and molecular findings of 11 Egyptian patients from 7 unrelated consanguineous families with clinical features of ARRS. Mutation analyses of ROR2 gene identified five pathogenic mutations distributed all over the gene. The identified mutations included four novel (G326A, D166H, S677F, and R528Q) and one previously reported (Y192D). Our results extend the number of ROR2 mutations identified so far, suggest a founder effect in the Egyptian population, and emphasize the important role of genetic testing in proper counseling and patients' management.
- 18 August 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (12) , 3054-3061
Clinical and molecular characterization of seven Egyptian families with autosomal recessive robinow syndrome: Identification of four novel ROR2 gene mutations
Robinow syndrome (RS) is a rare genetic disorder characterized by limb shortening, genital hypoplasia, and craniofacial/orodental abnormalities. The syndrome follows both autosomal dominant and recessive patterns of inheritance with similar phenotypic presentation and overlapping features. Autosomal recessive Robinow syndrome (ARRS) is caused by mutations in the ROR2 gene. Here, we present the clinical, radiological and molecular findings of 11 Egyptian patients from 7 unrelated consanguineous families with clinical features of ARRS. Mutation analyses of ROR2 gene identified five pathogenic mutations distributed all over the gene. The identified mutations included four novel (G326A, D166H, S677F, and R528Q) and one previously reported (Y192D). Our results extend the number of ROR2 mutations identified so far, suggest a founder effect in the Egyptian population, and emphasize the important role of genetic testing in proper counseling and patients' management.
- Open Access
- 6 April 2015
- Published by Springer Nature in Nature Genetics
- Vol. 47 (5) , 528-534
Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction
Joseph Gleeson and colleagues report that biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy marked by lysosome-autophagosome dysfunction. Their findings suggest a role for SNX14 in mediating lysosome-autophagosome fusion. Pediatric-onset ataxias often present clinically as developmental delay and intellectual disability, with prominent cerebellar atrophy as a key neuroradiographic finding. Here we describe a new clinically distinguishable recessive syndrome in 12 families with cerebellar atrophy together with ataxia, coarsened facial features and intellectual disability, due to truncating mutations in the sorting nexin gene SNX14, encoding a ubiquitously expressed modular PX domain–containing sorting factor. We found SNX14 localized to lysosomes and associated with phosphatidylinositol (3,5)-bisphosphate, a key component of late endosomes/lysosomes. Patient-derived cells showed engorged lysosomes and a slower autophagosome clearance rate upon autophagy induction by starvation. Zebrafish morphants for snx14 showed dramatic loss of cerebellar parenchyma, accumulation of autophagosomes and activation of apoptosis. Our results characterize a unique ataxia syndrome due to biallelic SNX14 mutations leading to lysosome-autophagosome dysfunction.
- 6 April 2015
- Published by Springer Nature in Nature Genetics
- Vol. 47 (5) , 528-534
Open AccessBiallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction
Joseph Gleeson and colleagues report that biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy marked by lysosome-autophagosome dysfunction. Their findings suggest a role for SNX14 in mediating lysosome-autophagosome fusion. Pediatric-onset ataxias often present clinically as developmental delay and intellectual disability, with prominent cerebellar atrophy as a key neuroradiographic finding. Here we describe a new clinically distinguishable recessive syndrome in 12 families with cerebellar atrophy together with ataxia, coarsened facial features and intellectual disability, due to truncating mutations in the sorting nexin gene SNX14, encoding a ubiquitously expressed modular PX domain–containing sorting factor. We found SNX14 localized to lysosomes and associated with phosphatidylinositol (3,5)-bisphosphate, a key component of late endosomes/lysosomes. Patient-derived cells showed engorged lysosomes and a slower autophagosome clearance rate upon autophagy induction by starvation. Zebrafish morphants for snx14 showed dramatic loss of cerebellar parenchyma, accumulation of autophagosomes and activation of apoptosis. Our results characterize a unique ataxia syndrome due to biallelic SNX14 mutations leading to lysosome-autophagosome dysfunction.
- 20 January 2014
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 27 (9-10) , 873-8
Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
To study the vitamin D receptor (VDR) gene in five Egyptian patients with severe rickets and the clinical features of hereditary vitamin D-resistant rickets, including hypocalcemia, hypophosphatemia, total alopecia, and elevated serum levels of 1,25-dihydroxyvitamin D. We amplified and sequenced DNA samples from blood from the patients, their parents, and available family members. DNA sequence analyses of the VDR gene showed three novel mutations (p.Y295X, p.R343C, and p.R391H) and a previously reported one (p.R30X) in four patients, whereas no mutation was found in one patient. Mutations cosegregated perfectly with affected individuals in all families, and did not exist in unaffected family members or 200 ethnically matched chromosomes. Three novel deleterious mutations in the VDR ligand-binding domain were identified, which are expected to render the VDR nonfunctional. Successful treatment with frequent high doses of oral calcium and calcidol was evident in all patients; however, hair growth occurred only in one patient.
- 20 January 2014
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 27 (9-10) , 873-8
Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
To study the vitamin D receptor (VDR) gene in five Egyptian patients with severe rickets and the clinical features of hereditary vitamin D-resistant rickets, including hypocalcemia, hypophosphatemia, total alopecia, and elevated serum levels of 1,25-dihydroxyvitamin D. We amplified and sequenced DNA samples from blood from the patients, their parents, and available family members. DNA sequence analyses of the VDR gene showed three novel mutations (p.Y295X, p.R343C, and p.R391H) and a previously reported one (p.R30X) in four patients, whereas no mutation was found in one patient. Mutations cosegregated perfectly with affected individuals in all families, and did not exist in unaffected family members or 200 ethnically matched chromosomes. Three novel deleterious mutations in the VDR ligand-binding domain were identified, which are expected to render the VDR nonfunctional. Successful treatment with frequent high doses of oral calcium and calcidol was evident in all patients; however, hair growth occurred only in one patient.